StockData
RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP

Regen BioPharma Inc

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$0.00+0.00 (+50.00%)

Close on Oct 19, 2026

Market cap
$92.33K
P/E (TTM)
–
Dividend yield
–

Regen BioPharma Inc revenue by segment

No segment breakdown reported

Regen BioPharma does not break out revenue by segment, region or product in the tagged data of its filings for this period type.